Review



sglt2 primary antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Proteintech sglt2 primary antibody
    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of <t>Slc5a2</t> (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.
    Sglt2 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 51 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/bio_rxiv__64898__2026__03__24__714065-262-40-43?v=Proteintech
    Average 94 stars, based on 51 article reviews
    sglt2 primary antibody - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "Insulin-independent glucose uptake in skeletal muscle by coupled SGLT and Na,K-ATPase transport"

    Article Title: Insulin-independent glucose uptake in skeletal muscle by coupled SGLT and Na,K-ATPase transport

    Journal: bioRxiv

    doi: 10.64898/2026.03.24.714065

    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of Slc5a2 (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.
    Figure Legend Snippet: 889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of Slc5a2 (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.

    Techniques Used: Reverse Transcription, Amplification, Agarose Gel Electrophoresis, Sequencing, Positive Control, Control

    a – c Confocal sections of fresh-frozen mouse tibialis anterior muscle dual-labeled with primary antibodies against Na,K-ATPase-α2 (green) and SGLT2 (red), and merged image. Scale bar 50 μm. d – f Longitudinal section of paraformaldehyde-fixed EDL fibers dual-labeled with MAP17 (green) and SGLT2 (red) antibodies, and merged image. Scale bar 13.5 μm. g – i cross-sections of mouse soleus muscle dual-labeled with myosin type I (green) and SGLT2 (red) antibodies, and merged image. Scale bar 145 μm. j – l Human vastus lateralis muscle dual-labeled with primary antibodies against MAP17 (green) and SGL2 (red), and merged image. Scale bar 145 μm. 10 μm sections. Images are representative of a minimum of three sections from each tissue sample. Negative controls included the secondary antibody and no primary antibody, and showed no signal for all sections (data not shown). Western Blot of mouse hindlimb skeletal muscle lysate (140 μg per lane) and mouse whole kidney lysate (20 μg per lane), labeled with the same SGLT2 antibody. n Western Blot of plasma membranes purified from mouse hindlimb skeletal muscle labeled with the same antibody. Muscle and kidney lysates were solubilized and denatured using a standard loading buffer with 2.5% SDS, 50 μM β-ME, and heated at 37 C for 30 min. o, p Western blots of purified plasma membranes from mouse hindlimb skeletal muscle (40 μg per lane) labeled with the same antibody used for IHC (PT) or an independent SGLT2 antibody (Abcam). The same muscle preparation was treated identically up to the antibody incubation step. This membrane preparation was solubilized and denatured more aggressively using 5% SDS, 100 mM DTT and heating at 65C for 15 min. q, r positive controls: human kidney cortical epithelial cells labeled with PT or Abcam antibodies. Western Blot images are representative of 3-4 blots obtained using 3 independent kidney and muscle samples. Control images without primary antibody and after Ponceau staining are provided in . Western blot images are representative of 4 blots obtained using 3 independent kidney and muscle samples.
    Figure Legend Snippet: a – c Confocal sections of fresh-frozen mouse tibialis anterior muscle dual-labeled with primary antibodies against Na,K-ATPase-α2 (green) and SGLT2 (red), and merged image. Scale bar 50 μm. d – f Longitudinal section of paraformaldehyde-fixed EDL fibers dual-labeled with MAP17 (green) and SGLT2 (red) antibodies, and merged image. Scale bar 13.5 μm. g – i cross-sections of mouse soleus muscle dual-labeled with myosin type I (green) and SGLT2 (red) antibodies, and merged image. Scale bar 145 μm. j – l Human vastus lateralis muscle dual-labeled with primary antibodies against MAP17 (green) and SGL2 (red), and merged image. Scale bar 145 μm. 10 μm sections. Images are representative of a minimum of three sections from each tissue sample. Negative controls included the secondary antibody and no primary antibody, and showed no signal for all sections (data not shown). Western Blot of mouse hindlimb skeletal muscle lysate (140 μg per lane) and mouse whole kidney lysate (20 μg per lane), labeled with the same SGLT2 antibody. n Western Blot of plasma membranes purified from mouse hindlimb skeletal muscle labeled with the same antibody. Muscle and kidney lysates were solubilized and denatured using a standard loading buffer with 2.5% SDS, 50 μM β-ME, and heated at 37 C for 30 min. o, p Western blots of purified plasma membranes from mouse hindlimb skeletal muscle (40 μg per lane) labeled with the same antibody used for IHC (PT) or an independent SGLT2 antibody (Abcam). The same muscle preparation was treated identically up to the antibody incubation step. This membrane preparation was solubilized and denatured more aggressively using 5% SDS, 100 mM DTT and heating at 65C for 15 min. q, r positive controls: human kidney cortical epithelial cells labeled with PT or Abcam antibodies. Western Blot images are representative of 3-4 blots obtained using 3 independent kidney and muscle samples. Control images without primary antibody and after Ponceau staining are provided in . Western blot images are representative of 4 blots obtained using 3 independent kidney and muscle samples.

    Techniques Used: Labeling, Western Blot, Clinical Proteomics, Purification, Incubation, Membrane, Control, Staining


    Figure Legend Snippet:

    Techniques Used:



    Similar Products

    94
    Alomone Labs anti sglt2 primary antibody
    Anti Sglt2 Primary Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/pm34500107-148-18-5?v=Alomone+Labs
    Average 94 stars, based on 1 article reviews
    anti sglt2 primary antibody - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Proteintech sglt2 primary antibody
    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of <t>Slc5a2</t> (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.
    Sglt2 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/bio_rxiv__64898__2026__03__24__714065-262-40-43?v=Proteintech
    Average 94 stars, based on 1 article reviews
    sglt2 primary antibody - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher primary antibodies against sglt2 pa5-101893
    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of <t>Slc5a2</t> (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.
    Primary Antibodies Against Sglt2 Pa5 101893, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/pmc11960209-55-7-38?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    primary antibodies against sglt2 pa5-101893 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences primary antibodies against sglt2
    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of <t>Slc5a2</t> (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.
    Primary Antibodies Against Sglt2, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/pm38278341-100-37-44?v=Affinity+Biosciences
    Average 90 stars, based on 1 article reviews
    primary antibodies against sglt2 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals primary antibodies directed against sglt2
    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of <t>Slc5a2</t> (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.
    Primary Antibodies Directed Against Sglt2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/pm37759444-116-15-18?v=Novus+Biologicals
    Average 90 stars, based on 1 article reviews
    primary antibodies directed against sglt2 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc primary antibodies incubation 255 against sglt2
    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of <t>Slc5a2</t> (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.
    Primary Antibodies Incubation 255 Against Sglt2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/10__2139_slash_ssrn__4168690-119-5-12?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    primary antibodies incubation 255 against sglt2 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Jackson Laboratory primary antibodies against sglt2
    Expression of <t>SGLT2</t> in rat liver and LO2 and HepG2 cells. (A) Western blot analysis and IHC staining demonstrate the protein expression level of SGLT2 in rat liver and kidney tissues. (B) Western blot analysis and immunofluorescence staining show the expression of SGLT2 in human hepatic cell lines.
    Primary Antibodies Against Sglt2, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/pmc08176308-67-32-50?v=Jackson+Laboratory
    Average 90 stars, based on 1 article reviews
    primary antibodies against sglt2 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc rat sglt2 primary antibody
    Expression of <t>SGLT2</t> in rat liver and LO2 and HepG2 cells. (A) Western blot analysis and IHC staining demonstrate the protein expression level of SGLT2 in rat liver and kidney tissues. (B) Western blot analysis and immunofluorescence staining show the expression of SGLT2 in human hepatic cell lines.
    Rat Sglt2 Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sglt2+primary+antibody/pm31540429-113-0-7?v=Cell+Signaling+Technology+Inc
    Average 90 stars, based on 1 article reviews
    rat sglt2 primary antibody - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of Slc5a2 (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.

    Journal: bioRxiv

    Article Title: Insulin-independent glucose uptake in skeletal muscle by coupled SGLT and Na,K-ATPase transport

    doi: 10.64898/2026.03.24.714065

    Figure Lengend Snippet: 889 ng of DNAse-treated kidney RNA ( a ) and 927 ng of DNAse-treated muscle RNA ( b ) was reverse transcribed, the cDNA amplified by PCR, and electrophoresed on a 1% agarose gel. Lanes 1 & 20, 1 kb+ ladder; Lanes 2−7, kidney RNA with primers that target regions of Slc5a2 (primer sets 1−6, Table S3). Lane 8, kidney RNA amplified with a near full-length primer set (1896 bp of the 2070 bp coding sequence); lane 9, GAPDH (positive control); lanes 10−15, muscle RNA amplified with the same region-specific primers used for kidney; lane 16, muscle RNA amplified with the same full-length primer set used for kidney; lane 17, GAPDH ; lane 18, kidney no-RT control with GAPDH primers; lane 19, muscle no-RT control with GAPDH primers. cDNA from mouse kidney and hindlimb skeletal muscle was amplified using primer sets 1−6, 8, and GAPDH (Table S3). The same amount of cDNA was used as template for PCR of kidney and muscle. Gel is representative of 4 independent assays. The faint band in lane 15 (muscle, primer set 6 within exon 14), may be signal from the ubiquitous gene Rusf1 which contains sequences shared with exon 14 of Slc5a2 . For all primer sets, the melt curve peaks had identical melt curve/Tm values in kidney and muscle.

    Article Snippet: Proteins were transferred to PDVF membranes overnight at 4 °C, 30 V. Membranes were stained with Ponceau S and washed, then incubated in TBST buffer with 2% nonfat dry milk for 1h at room temperature, followed by incubation with an SGLT2 primary antibody (ProteinTech 24654-1-AP , 1:500, 24 h; or Abcam ab37296 , 1:250, 48 h), washed 3×15 min in TBST buffer, incubated with secondary antibody (Licor IRDye @680 goat anti-Rabbit 925-68071, 1:10000)1.5 h at room temperature, washed in TBST buffer 3×15 min, and imaged (Odyssey Imager, LICORbio).

    Techniques: Reverse Transcription, Amplification, Agarose Gel Electrophoresis, Sequencing, Positive Control, Control

    a – c Confocal sections of fresh-frozen mouse tibialis anterior muscle dual-labeled with primary antibodies against Na,K-ATPase-α2 (green) and SGLT2 (red), and merged image. Scale bar 50 μm. d – f Longitudinal section of paraformaldehyde-fixed EDL fibers dual-labeled with MAP17 (green) and SGLT2 (red) antibodies, and merged image. Scale bar 13.5 μm. g – i cross-sections of mouse soleus muscle dual-labeled with myosin type I (green) and SGLT2 (red) antibodies, and merged image. Scale bar 145 μm. j – l Human vastus lateralis muscle dual-labeled with primary antibodies against MAP17 (green) and SGL2 (red), and merged image. Scale bar 145 μm. 10 μm sections. Images are representative of a minimum of three sections from each tissue sample. Negative controls included the secondary antibody and no primary antibody, and showed no signal for all sections (data not shown). Western Blot of mouse hindlimb skeletal muscle lysate (140 μg per lane) and mouse whole kidney lysate (20 μg per lane), labeled with the same SGLT2 antibody. n Western Blot of plasma membranes purified from mouse hindlimb skeletal muscle labeled with the same antibody. Muscle and kidney lysates were solubilized and denatured using a standard loading buffer with 2.5% SDS, 50 μM β-ME, and heated at 37 C for 30 min. o, p Western blots of purified plasma membranes from mouse hindlimb skeletal muscle (40 μg per lane) labeled with the same antibody used for IHC (PT) or an independent SGLT2 antibody (Abcam). The same muscle preparation was treated identically up to the antibody incubation step. This membrane preparation was solubilized and denatured more aggressively using 5% SDS, 100 mM DTT and heating at 65C for 15 min. q, r positive controls: human kidney cortical epithelial cells labeled with PT or Abcam antibodies. Western Blot images are representative of 3-4 blots obtained using 3 independent kidney and muscle samples. Control images without primary antibody and after Ponceau staining are provided in . Western blot images are representative of 4 blots obtained using 3 independent kidney and muscle samples.

    Journal: bioRxiv

    Article Title: Insulin-independent glucose uptake in skeletal muscle by coupled SGLT and Na,K-ATPase transport

    doi: 10.64898/2026.03.24.714065

    Figure Lengend Snippet: a – c Confocal sections of fresh-frozen mouse tibialis anterior muscle dual-labeled with primary antibodies against Na,K-ATPase-α2 (green) and SGLT2 (red), and merged image. Scale bar 50 μm. d – f Longitudinal section of paraformaldehyde-fixed EDL fibers dual-labeled with MAP17 (green) and SGLT2 (red) antibodies, and merged image. Scale bar 13.5 μm. g – i cross-sections of mouse soleus muscle dual-labeled with myosin type I (green) and SGLT2 (red) antibodies, and merged image. Scale bar 145 μm. j – l Human vastus lateralis muscle dual-labeled with primary antibodies against MAP17 (green) and SGL2 (red), and merged image. Scale bar 145 μm. 10 μm sections. Images are representative of a minimum of three sections from each tissue sample. Negative controls included the secondary antibody and no primary antibody, and showed no signal for all sections (data not shown). Western Blot of mouse hindlimb skeletal muscle lysate (140 μg per lane) and mouse whole kidney lysate (20 μg per lane), labeled with the same SGLT2 antibody. n Western Blot of plasma membranes purified from mouse hindlimb skeletal muscle labeled with the same antibody. Muscle and kidney lysates were solubilized and denatured using a standard loading buffer with 2.5% SDS, 50 μM β-ME, and heated at 37 C for 30 min. o, p Western blots of purified plasma membranes from mouse hindlimb skeletal muscle (40 μg per lane) labeled with the same antibody used for IHC (PT) or an independent SGLT2 antibody (Abcam). The same muscle preparation was treated identically up to the antibody incubation step. This membrane preparation was solubilized and denatured more aggressively using 5% SDS, 100 mM DTT and heating at 65C for 15 min. q, r positive controls: human kidney cortical epithelial cells labeled with PT or Abcam antibodies. Western Blot images are representative of 3-4 blots obtained using 3 independent kidney and muscle samples. Control images without primary antibody and after Ponceau staining are provided in . Western blot images are representative of 4 blots obtained using 3 independent kidney and muscle samples.

    Article Snippet: Proteins were transferred to PDVF membranes overnight at 4 °C, 30 V. Membranes were stained with Ponceau S and washed, then incubated in TBST buffer with 2% nonfat dry milk for 1h at room temperature, followed by incubation with an SGLT2 primary antibody (ProteinTech 24654-1-AP , 1:500, 24 h; or Abcam ab37296 , 1:250, 48 h), washed 3×15 min in TBST buffer, incubated with secondary antibody (Licor IRDye @680 goat anti-Rabbit 925-68071, 1:10000)1.5 h at room temperature, washed in TBST buffer 3×15 min, and imaged (Odyssey Imager, LICORbio).

    Techniques: Labeling, Western Blot, Clinical Proteomics, Purification, Incubation, Membrane, Control, Staining

    Journal: bioRxiv

    Article Title: Insulin-independent glucose uptake in skeletal muscle by coupled SGLT and Na,K-ATPase transport

    doi: 10.64898/2026.03.24.714065

    Figure Lengend Snippet:

    Article Snippet: Proteins were transferred to PDVF membranes overnight at 4 °C, 30 V. Membranes were stained with Ponceau S and washed, then incubated in TBST buffer with 2% nonfat dry milk for 1h at room temperature, followed by incubation with an SGLT2 primary antibody (ProteinTech 24654-1-AP , 1:500, 24 h; or Abcam ab37296 , 1:250, 48 h), washed 3×15 min in TBST buffer, incubated with secondary antibody (Licor IRDye @680 goat anti-Rabbit 925-68071, 1:10000)1.5 h at room temperature, washed in TBST buffer 3×15 min, and imaged (Odyssey Imager, LICORbio).

    Techniques:

    Expression of SGLT2 in rat liver and LO2 and HepG2 cells. (A) Western blot analysis and IHC staining demonstrate the protein expression level of SGLT2 in rat liver and kidney tissues. (B) Western blot analysis and immunofluorescence staining show the expression of SGLT2 in human hepatic cell lines.

    Journal: Frontiers in Pharmacology

    Article Title: Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway

    doi: 10.3389/fphar.2021.589273

    Figure Lengend Snippet: Expression of SGLT2 in rat liver and LO2 and HepG2 cells. (A) Western blot analysis and IHC staining demonstrate the protein expression level of SGLT2 in rat liver and kidney tissues. (B) Western blot analysis and immunofluorescence staining show the expression of SGLT2 in human hepatic cell lines.

    Article Snippet: Cells were fixed with 4% paraformaldehyde for 10 min, permeabilized in 0.25% Triton X-100 for 15 min and blocked with 5% normal goat serum for 1 h. Samples were incubated with primary antibodies against SGLT2 (1:100) and LC3B (1:100) at 4°C overnight followed by the incubation with secondary antibodies (1:100; Jackson Laboratories) for 1 h at room temperature, and the staining of 4′,6-diamidino-2-phenylindole (DAPI; 1:100; Invitrogen) for 4min.

    Techniques: Expressing, Western Blot, Immunohistochemistry, Immunofluorescence, Staining